Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22
Phase 41

Trial Status

Completed3
Terminated1

Role Distribution

Principal Investigator3
Other Roles1
PI Rate75%

Activity Timeline

Clinical Trials (4)

NCT00364819Phase 1/2Completed
Initial Study of Rituximab to Treat Primary Biliary Cirrhosis
Primary Biliary Cirrhosis
Studydirector
NCT02078882Phase 4Completed
Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis
Primary Biliary Cirrhosis
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of California, Davis

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT00364819Phase 1/2StudyDirector

Initial Study of Rituximab to Treat Primary Biliary Cirrhosis

Primary Biliary Cirrhosis
Completed
NCT00529204Phase 2PrincipalInvestigator

Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease

Diabetes ComplicationsFatty Liver
Terminated
NCT02078882Phase 4PrincipalInvestigator

Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis

Primary Biliary Cirrhosis
Completed
NCT02477462PrincipalInvestigator

Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients

Primary Biliary Cirrhosis
Completed

All 4 trials loaded